Cornerstone Planning Group LLC Dia Medica Therapeutics Inc. Transaction History
Cornerstone Planning Group LLC
- $624 Billion
- Q3 2025
A detailed history of Cornerstone Planning Group LLC transactions in Dia Medica Therapeutics Inc. stock. As of the latest transaction made, Cornerstone Planning Group LLC holds 6 shares of DMAC stock, worth $35. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6
Previous 80
92.5%
Holding current value
$35
Previous $359,000
111.14%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding DMAC
# of Institutions
64Shares Held
5.72MCall Options Held
0Put Options Held
0-
Paragon Associates & Paragon Associates Ii Joint Venture Dallas, TX875KShares$5.22 Million11.8% of portfolio
-
Geode Capital Management, LLC Boston, MA712KShares$4.24 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA665KShares$3.96 Million0.0% of portfolio
-
First Manhattan CO New York, NY606KShares$3.61 Million0.01% of portfolio
-
State Street Corp Boston, MA477KShares$2.84 Million0.0% of portfolio
About DiaMedica Therapeutics Inc.
- Ticker DMAC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,443,100
- Market Cap $158M
- Description
- DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, develops treatments for neurological and kidney diseases. The company's lead drug candidate is DM199, a recombinant human tissue kallikrein-1 protein, which is in Phase 2 REDUX trial for the treatment of patients with moderate or severe chronic kidney disease caused by Type...